An announcement from Vicarious Surgical ( ($RBOT) ) is now available. On December 1, 2025, Beverly Huss and Randy Clark resigned from Vicarious ...

Medtronic (NYSE: MDT), a global leader in surgical innovation, today announced the U.S. Food and Drug Administration (FDA) has cleared the Hugo™ robotic-assisted surgery (RAS) system for use in ...

From concrete that outlasts modern formulas to surgical tools and engineering innovations centuries ahead of their time, Rome’s technology was anything but primitive. These breakthroughs reveal a ...

The center brought a mobile lab to its campus on Tuesday, allowing patients to get a firsthand look at the tools doctors ...

One fund just made a bold move on an eye-care giant—here’s why it may signal a deeper shift in the company’s long-term ...

Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic ...

The global surgical robotics market is forecast to grow at a compound annual growth rate (CAGR) of 15% between 2025 and 2030.

Madhavbaug’s Ayurvedic heart blockage reversal program not only naturally increases heart health but also provides ...

The long-awaited FDA clearance sets up a showdown in the surgical robotics market between Medtronic and Intuitive Surgical.

Vicarious Surgical (RBOT) stock was trading higher Wednesday pre-market after the robotics technology company delivered an improved cash burn outlook.

As Hollywood moves toward new horizons. Dakota Jonsson has become a symbol of a growing trend: celebrities who choose to ...

Industry data and patient mobility patterns highlight Istanbul’s rising influence in complex dental rehabilitation.